Visual compatibility of oritavancin diphosphate with selected coadministered drugs during simulated Y-site administration

American Journal of Health-System Pharmacy

Volumn 67, Issue 19, 2010, Pages 1640-1644

  Kumar, Atul ^a   Mann, Henry J ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Antiinfective agents; Color; Concentration; Dextrose; Diluents; Hydrogen ion concentration; Incompatibilities; Injections; Oritavancin diphosphate; Precipitation; Stability; Storage

Indexed keywords

ADRENALIN; AMINOPHYLLINE; AMPHOTERICIN B; BUMETANIDE; CIMETIDINE; CIPROFLOXACIN; CLINDAMYCIN PHOSPHATE; DEXMEDETOMIDINE; DOBUTAMINE; DOPAMINE; FAMOTIDINE; FENTANYL CITRATE; FLUCONAZOLE; FUROSEMIDE; GENTAMICIN; GLUCONATE CALCIUM; GLYCERYL TRINITRATE; HALOPERIDOL; HEPARIN; HUMAN INSULIN; HYDROCORTISONE SODIUM SUCCINATE; LORAZEPAM; MEROPENEM; METRONIDAZOLE; MIDAZOLAM; MORPHINE SULFATE; NORADRENALIN BITARTRATE; ORITAVANCIN; PANCURONIUM BROMIDE; UNINDEXED DRUG; ANTIINFECTIVE AGENT; GLUCOSE; GLYCOPEPTIDE;

ARTICLE; COLOR; DRUG FORMULATION; DRUG INCOMPATIBILITY; DRUG MIXTURE; DRUG SOLUTION; EMERGENCY CARE; MEDICAL CARE; PH; PRIORITY JOURNAL; ROOM TEMPERATURE; SIMULATION; CHEMISTRY; DRUG STABILITY; DRUG STORAGE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; PRECIPITATION; SOLUTION AND SOLUBILITY; TIME;

ANTI-BACTERIAL AGENTS; CHEMICAL PRECIPITATION; COLOR; DRUG INCOMPATIBILITY; DRUG STABILITY; DRUG STORAGE; GLUCOSE; GLYCOPEPTIDES; HUMANS; HYDROGEN-ION CONCENTRATION; INFUSIONS, INTRAVENOUS; PHARMACEUTICAL SOLUTIONS; TIME FACTORS;

EID: 79952110581     PISSN: 10792082     EISSN: 15352900     Source Type: Journal    
DOI: 10.2146/ajhp100011     Document Type: Article

References (3)

1. Allen NE, Nicas TI. Mechanism of action of oritavancin and related glycopeptide antibiotics. FEMS Microbiol Rev. 2003; 26:511-32. (Pubitemid 36187412)
2. Allen LV, Levinson RS, Phisutsinthop D. Compatibility of various admixtures with secondary additives at Y-injection sites of intravenous administration sets. Am J Hosp Pharm. 1977; 34:939-43. (Pubitemid 8147103)
3. Trissel LA, Saenz CA, Ogundele AB et al. Physical compatibility of pemetrexed disodium with other drugs during simulated Y-site administration. Am J Health-Syst Pharm. 2004; 61:2289-93.